Koyfin Home > Directory > Health Care > Adamas Pharma

Adamas Pharma Price Chart ADMS

Historical daily share price chart and data for Adamas Pharma since 2014 adjusted for splits and dividends. The latest closing price for Adamas Pharma as of September 22, 2020 is $4.76.
  • In 2020 the stock opened at $4.16 and closed at $4.76 for a gain of 13% YTD.
  • In 2019 the stock opened at $8.36 and closed at $3.79 for a loss of -121%.
  • In 2018 the stock opened at $33.67 and closed at $8.54 for a loss of -294%.
  • In 2017 the stock opened at $16.99 and closed at $33.89 for a gain of 50%.
View Chart On Koyfin

Adamas Pharma Summary

Stock Symbol: ADMS

Adamas Pharma Company Info

Adamas Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of medicines for patients suffering from chronic neurologic disorders in the United States. The company offers GOCOVRI, an extended release capsule for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications. It is also developing ADS-5102 that is in Phase III clinical study to treat walking impairment in patients with multiple sclerosis and other indications; and ADS-4101, which has completed two Phase I studies for treating partial onset seizures in patients with epilepsy. In addition, the company offers Namzaric (memantine hydrochloride extended release and donepezil hydrochloride) capsules for the treatment of moderate to severe dementia of an Alzheimer’s type. The company was formerly known as NeuroMolecular Pharmaceuticals, Inc. and changed its name to Adamas Pharmaceuticals, Inc. in July 2007. Adamas Pharmaceuticals, Inc. was founded in 2000 and is headquartered in Emeryville, California.
Market Cap
Dividend Yield
0 %
Beta vs SPX
Short Interest
85.54 %
30D Volatility
Hedge Fund Held
14.4 %

Last 10 Days of ADMS Prices